Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

New research by Swansea University and the University of Cambridge has revealed the causes and devastating impacts of delays – that can last decades - in diagnosing lupus, an auto-immune condition.

Join the Choose Healthy Life 2025 National Conclave virtually on Monday, June 23rd at 10:00 a.m. ET! Hear keynote speaker Reverend Al Sharpton and enjoy a special performance by gospel singer JJ ...

New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays—that ...

Circular rashes may be puzzling—and alarming. The instant most individuals catch sight of a circle or ring-shaped area on the ...

She said: “Lupus was seen as something that was life-limiting. That’s changed and over the last few years – there’s really ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

Lupus causes a higher risk of kidney disease and other complications in Black women. Learn why early diagnosis and awareness are vital.

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

These manifestations are often part of the systemic activity or flare, which can be painful and have a considerable impact on quality of life,” said principal investigator Prof. Eric Morand, from ...